Carmen Lefaucheur

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

Mark Haas, Alexandre Loupy, Carmen Lefaucheur et al. · American Journal of Transplantation · 2017 · 1K citations · Full text

Medicine, Nephrology, Pathology +17

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

Alexandre Loupy, Carmen Lefaucheur, Déwi Vernerey et al. · New England Journal of Medicine · 2013 · 833 citations · Full text

Life Sciences, Immunology, Surgery +17

The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection

Alexandre Loupy, Mark Haas, Candice Roufosse et al. · American Journal of Transplantation · 2020 · 808 citations · Full text

Medicine, Nephrology, Pathology +17

Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

Carmen Lefaucheur, Alexandre Loupy, Gary S. Hill et al. · Journal of the American Society of Nephrology · 2010 · 775 citations · Full text

Life Sciences, Immunology, Surgery +17

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

Alexandre Loupy, Mark Haas, Kim Solez et al. · American Journal of Transplantation · 2016 · 624 citations · Full text

Life Sciences, Immunology, Pathology +17